Header Logo

Connection

Neil Martinson to Antitubercular Agents

Back to Details
This is a "connection" page, showing publications Neil Martinson has written about Antitubercular Agents.
Neil Martinson
Connection Strength
5,475
Antitubercular Agents
  1. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
    View in: PubMed
    Score: 0,604
  2. Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports. Int J Tuberc Lung Dis. 2014 Aug; 18(8):1005.
    View in: PubMed
    Score: 0,377
  3. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa. Int J Tuberc Lung Dis. 2013 Sep; 17(9):1199-205.
    View in: PubMed
    Score: 0,354
  4. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011 Jul 07; 365(1):11-20.
    View in: PubMed
    Score: 0,305
  5. Survival in XDR TB: shifting the curve and shifting the paradigm. J Acquir Immune Defic Syndr. 2011 Jun 01; 57(2):89-91.
    View in: PubMed
    Score: 0,303
  6. Additive effects of isoniazid preventive therapy and HAART. AIDS. 2009 Jul 17; 23(11):1446-7.
    View in: PubMed
    Score: 0,266
  7. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009 Mar 13; 23(5):631-6.
    View in: PubMed
    Score: 0,259
  8. Linking the global positioning system (GPS) to a personal digital assistant (PDA) to support tuberculosis control in South Africa: a pilot study. Int J Health Geogr. 2006 Aug 16; 5:34.
    View in: PubMed
    Score: 0,217
  9. Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrob Agents Chemother. 2024 May 02; 68(5):e0158323.
    View in: PubMed
    Score: 0,184
  10. Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial. J Acquir Immune Defic Syndr. 2022 12 01; 91(4):397-402.
    View in: PubMed
    Score: 0,168
  11. Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Ann Intern Med. 2021 10; 174(10):1367-1376.
    View in: PubMed
    Score: 0,154
  12. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
    View in: PubMed
    Score: 0,151
  13. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis. Front Immunol. 2021; 12:623941.
    View in: PubMed
    Score: 0,149
  14. Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort. Clin Infect Dis. 2020 09 12; 71(6):1419-1426.
    View in: PubMed
    Score: 0,144
  15. Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV. Antimicrob Agents Chemother. 2020 02 21; 64(3).
    View in: PubMed
    Score: 0,138
  16. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. AIDS. 2020 01 01; 34(1):63-71.
    View in: PubMed
    Score: 0,137
  17. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 2018 Dec 20; 19(1):693.
    View in: PubMed
    Score: 0,128
  18. Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa. Int J Tuberc Lung Dis. 2018 12 01; 22(12):1435-1442.
    View in: PubMed
    Score: 0,127
  19. Occult rifampicin-resistant tuberculosis: better assays are needed. Lancet Infect Dis. 2018 12; 18(12):1293-1295.
    View in: PubMed
    Score: 0,126
  20. The effect of partner HIV status on motivation to take antiretroviral and isoniazid preventive therapies: a conjoint analysis. AIDS Care. 2018 10; 30(10):1298-1305.
    View in: PubMed
    Score: 0,121
  21. Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial. Ann Intern Med. 2017 11 21; 167(10):689-697.
    View in: PubMed
    Score: 0,118
  22. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. J Antimicrob Chemother. 2017 07 01; 72(7):2028-2034.
    View in: PubMed
    Score: 0,115
  23. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015 Dec 05; 386(10010):2344-53.
    View in: PubMed
    Score: 0,103
  24. Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov. 2015 Aug; 14(8):511-2.
    View in: PubMed
    Score: 0,101
  25. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health. 2013 Jan; 18(1):109-16.
    View in: PubMed
    Score: 0,084
  26. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc. 2011 Jun; 8(3):288-93.
    View in: PubMed
    Score: 0,076
  27. Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis. N Engl J Med. 2024 Dec 19; 391(24):2315-2326.
    View in: PubMed
    Score: 0,048
  28. A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis. NEJM Evid. 2025 Jan; 4(1):EVIDoa2400190.
    View in: PubMed
    Score: 0,048
  29. SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials. 2023 Jun 28; 24(1):435.
    View in: PubMed
    Score: 0,044
  30. Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine. Contemp Clin Trials. 2023 06; 129:107173.
    View in: PubMed
    Score: 0,043
  31. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. Lancet Respir Med. 2023 09; 11(9):782-790.
    View in: PubMed
    Score: 0,043
  32. National survey in South Africa reveals high tuberculosis prevalence among previously treated people. Lancet Infect Dis. 2022 09; 22(9):1273.
    View in: PubMed
    Score: 0,041
  33. An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study). Am J Respir Crit Care Med. 2022 May 15; 205(10):1214-1227.
    View in: PubMed
    Score: 0,040
  34. Promoting Tuberculosis Preventive Therapy for People Living with HIV in South Africa: Interventions Hindered by Complicated Clinical Guidelines and Imbalanced Patient-Provider Dynamics. AIDS Behav. 2020 Apr; 24(4):1106-1117.
    View in: PubMed
    Score: 0,035
  35. Priorities among HIV-positive individuals for tuberculosis preventive therapies. Int J Tuberc Lung Dis. 2020 04 01; 24(4):396-402.
    View in: PubMed
    Score: 0,035
  36. Liquid mycobacterial culture outcomes after different sputum collection techniques before and during treatment. Tuberculosis (Edinb). 2019 05; 116:17-21.
    View in: PubMed
    Score: 0,033
  37. Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
    View in: PubMed
    Score: 0,030
  38. Propidium monoazide and Xpert MTB/RIF to quantify Mycobacterium tuberculosis cells. Tuberculosis (Edinb). 2016 12; 101:79-84.
    View in: PubMed
    Score: 0,027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.